Libra Group Social Responsibility

Concordia COVID-19 Webinar Series: Mastercard Therapeutics Accelerator

March 26, 2020 – On March 10th, a day before the World Health Organization (WHO) declared COVID-19 to be a pandemic and two days before the U.S. declared a national emergency, Mastercard, alongside the Bill & Melinda Gates Foundation and Wellcome Trust, launched the COVID-19 Therapeutics Accelerator. The Accelerator, designed to bring together resources and expertise in order to rapidly accelerate a treatment for COVID-19, represents one of the first high profile partnerships in response to the outbreak. This partnership brings together non-profit and private sector partners to collectively work together to develop, produce, scale, and distribute therapies, even in the face of significant financial barriers to R&D. These partners have brought their collective resources and experience together to design a path forward that could save millions around the world.

Moderated by Matthew Swift, Concordia Co-Founder, Chairman & CEO, we’ll hear first hand from Shamina Singh, Founder & President of the Center for Inclusive Growth and Executive Vice President of Corporate Sustainability at Mastercard about the Accelerator; how it came to be, the progress achieved, and what’s still needed from partners in the global health and funding spaces.


Contact us

We welcome communications relating to Libra Social Responsibility.

Please provide your contact details and message below and our team will be in touch with you.

* are required fields